0001013762-24-000388.txt : 20240722 0001013762-24-000388.hdr.sgml : 20240722 20240722143558 ACCESSION NUMBER: 0001013762-24-000388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240718 FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly William John CENTRAL INDEX KEY: 0001885525 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39384 FILM NUMBER: 241131135 MAIL ADDRESS: STREET 1: C/O VICARIOUS SURGICAL INC. STREET 2: 78 4TH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vicarious Surgical Inc. CENTRAL INDEX KEY: 0001812173 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 78 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (617) 868-1700 MAIL ADDRESS: STREET 1: 78 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: D8 Holdings Corp. DATE OF NAME CHANGE: 20200514 4 1 ownership.xml X0508 4 2024-07-18 0 0001812173 Vicarious Surgical Inc. RBOT 0001885525 Kelly William John C/O VICARIOUS SURGICAL INC. 78 FOURTH AVENUE WALTHAM MA 02451 0 1 0 0 CFO and Treasurer 0 Class A Common Stock 2024-07-18 4 S 0 27 7.9663 D 16798 D The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. /s/ Erin Checka, Attorney-in-Fact 2024-07-22